bioRxiv
BET Inhibitors Target the SCLC-N subtype Small Cell Lung Cancer by Blocking NEUROD1 Transactivation
Publication
, Preprint
Chen, H; Gesumaria, L; Park, Y-K; Oliver, T; Singer, D; Ge, K; Shrump, D
2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Chen, H., Gesumaria, L., Park, Y.-K., Oliver, T., Singer, D., Ge, K., & Shrump, D. (2021). BET Inhibitors Target the SCLC-N subtype Small Cell Lung Cancer by Blocking NEUROD1 Transactivation. bioRxiv. https://doi.org/10.1101/2021.10.25.465771
Chen, Haobin, Lisa Gesumaria, Young-Kwon Park, Trudy Oliver, Dinah Singer, Kai Ge, and David Shrump. “BET Inhibitors Target the SCLC-N subtype Small Cell Lung Cancer by Blocking NEUROD1 Transactivation.” BioRxiv, 2021. https://doi.org/10.1101/2021.10.25.465771.
Chen H, Gesumaria L, Park Y-K, Oliver T, Singer D, Ge K, et al. BET Inhibitors Target the SCLC-N subtype Small Cell Lung Cancer by Blocking NEUROD1 Transactivation. bioRxiv. 2021.
Chen, Haobin, et al. “BET Inhibitors Target the SCLC-N subtype Small Cell Lung Cancer by Blocking NEUROD1 Transactivation.” BioRxiv, 2021. Epmc, doi:10.1101/2021.10.25.465771.
Chen H, Gesumaria L, Park Y-K, Oliver T, Singer D, Ge K, Shrump D. BET Inhibitors Target the SCLC-N subtype Small Cell Lung Cancer by Blocking NEUROD1 Transactivation. bioRxiv. 2021.